Tudor Investment Corp’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-32,200
| Closed | -$316K | – | 1570 |
|
2017
Q1 | $316K | Buy |
+32,200
| New | +$316K | 0.01% | 961 |
|
2016
Q2 | – | Sell |
-70,121
| Closed | -$771K | – | 1800 |
|
2016
Q1 | $771K | Buy |
70,121
+2,543
| +4% | +$28K | 0.02% | 503 |
|
2015
Q4 | $622K | Sell |
67,578
-17,893
| -21% | -$165K | 0.02% | 609 |
|
2015
Q3 | $593K | Buy |
85,471
+57,161
| +202% | +$397K | 0.02% | 624 |
|
2015
Q2 | $278K | Sell |
28,310
-6,745
| -19% | -$66.2K | 0.01% | 1106 |
|
2015
Q1 | $311K | Sell |
35,055
-6,119
| -15% | -$54.3K | 0.01% | 1015 |
|
2014
Q4 | $361K | Sell |
41,174
-879
| -2% | -$7.71K | 0.01% | 918 |
|
2014
Q3 | $290K | Buy |
+42,053
| New | +$290K | 0.01% | 1015 |
|
2014
Q1 | – | Sell |
-35,700
| Closed | -$180K | – | 1498 |
|
2013
Q4 | $180K | Buy |
35,700
+7,600
| +27% | +$38.3K | 0.01% | 1111 |
|
2013
Q3 | $142K | Buy |
28,100
+2,300
| +9% | +$11.6K | 0.01% | 754 |
|
2013
Q2 | $128K | Buy |
+25,800
| New | +$128K | 0.01% | 749 |
|